Dear colleagues,
To extend the question related to ONJ (bisphosphonate-associated
osteonecrosis of the jaw):
Is there any bone-related biochemical profile being predictive of this
adverse drug event ?
Does it make sense to analyse bone markers once the complication has
occurred ?
Best regards,
Mike
--
****************************************
PD Dr. med. Michael Steiner
[log in to unmask]
Tel: +49-381-7022701
****************************************
Medizinisches Labor Rostock
Südring 81, D-18059 Rostock
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|